Analysis of renal function during telaprevir-based triple therapy for chronic hepatitis C

Telaprevir (TVR) is used for the treatment of chronic hepatitis C in a combination therapy with pegylated-interferon and ribavirin. Although renal dysfunction is one of the critical adverse outcomes of this treatment, little is known regarding the mechanism of its onset. The present study assessed t...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Exp Ther Med
Auteurs principaux: KOHJIMA, MOTOYUKI, KUROKAWA, MIHO, ENJOJI, MUNECHIKA, YOSHIMOTO, TSUYOSHI, NAKAMURA, TSUKASA, OHASHI, TOMOKO, FUKUIZUMI, KUNITAKA, HARADA, NAOHIKO, MURATA, YUSUKE, MATSUNAGA, KAZUHISA, KATO, MASAKI, KOTOH, KAZUHIRO, NAKAMUTA, MAKOTO
Format: Artigo
Langue:Inglês
Publié: D.A. Spandidos 2016
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4840744/
https://ncbi.nlm.nih.gov/pubmed/27168803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2016.3133
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires